title: Effects of immunomodulatory substances on phagocytosis of abeta(1-42) by human microglia.
abstract: Glial activation and increased inflammation characterize neuropathology in Alzheimer's disease (AD). The aim was to develop a model for studying phagocytosis of beta-amyloid (Abeta) peptide by human microglia and to test effects thereupon by immunomodulatory substances. Human CHME3 microglia showed intracellular Abeta(1-42) colocalized with lysosome-associated membrane protein-2, indicating phagocytosis. This was increased by interferon-gamma, and to a lesser degree with Protollin, a proteosome-based adjuvant. Secretion of brain-derived neurotrophic factor (BDNF) was decreased by Abeta(1-42) and by interferon-gamma and interleukin-1beta. These cytokines, but not Abeta(1-42), stimulated interleukin-6 release. Microglia which phagocytosed Abeta(1-42) exhibited a higher degree of expression of interleukin-1 receptor type I and inducible nitric oxide synthase. In conclusion, we show that human microglia are able to phagocytose Abeta(1-42) and that this is associated with expression of inflammatory markers. Abeta(1-42) and interferon-gamma decreased BDNF secretion suggesting a new neuropathological role for Abeta(1-42) and the inflammation accompanying AD.
authors.affiliation: Division of Neurodegeneration, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 141 86 Stockholm, Sweden.
authors.forename: Erik
authors.initials: E
authors.lastname: Hjorth
authors.forename: Dan
authors.initials: D
authors.lastname: Frenkel
authors.forename: Howard
authors.initials: H
authors.lastname: Weiner
authors.forename: Marianne
authors.initials: M
authors.lastname: Schultzberg
references.citation: Respir Physiol. 2001 Dec;129(1-2):71-81
references.pmid: 11738647
references.citation: Methods Find Exp Clin Pharmacol. 1991 Sep;13(7):455-8
references.pmid: 1784142
references.citation: J Biol Chem. 1996 Feb 23;271(8):4077-81
references.pmid: 8626743
references.citation: J Neuroimmune Pharmacol. 2006 Sep;1(3):212-22
references.pmid: 18040799
references.citation: J Neurosci. 2000 Sep 15;20(18):6888-97
references.pmid: 10995833
references.citation: Proc Natl Acad Sci U S A. 1989 Oct;86(19):7611-5
references.pmid: 2529544
references.citation: Methods. 1996 Aug;10(1):31-7
references.pmid: 8812642
references.citation: Exp Neurol. 2000 Apr;162(2):290-6
references.pmid: 10739635
references.citation: Neurosci Lett. 1995 Dec 29;202(1-2):17-20
references.pmid: 8787820
references.citation: Mol Chem Neuropathol. 1996 May-Aug;28(1-3):15-20
references.pmid: 8871937
references.citation: J Neurosci Res. 2002 Jul 1;69(1):94-103
references.pmid: 12111820
references.citation: Neurochem Int. 2001 Nov-Dec;39(5-6):381-91
references.pmid: 11578773
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2003 Aug;27(5):741-9
references.pmid: 12921904
references.citation: Annu Rev Cell Biol. 1994;10:373-403
references.pmid: 7888181
references.citation: Neurobiol Aging. 2000 May-Jun;21(3):383-421
references.pmid: 10858586
references.citation: J Biol Chem. 2000 Mar 17;275(11):7918-24
references.pmid: 10713108
references.citation: J Mol Neurosci. 2005;27(1):1-12
references.pmid: 16055942
references.citation: Nature. 1999 Jul 8;400(6740):173-7
references.pmid: 10408445
references.citation: Prog Brain Res. 1996;108:365-77
references.pmid: 8979814
references.citation: J Neurosci. 2005 Sep 7;25(36):8240-9
references.pmid: 16148231
references.citation: Brain Res. 1992 Jan 8;569(1):141-5
references.pmid: 1611474
references.citation: Neurobiol Dis. 2000 Dec;7(6 Pt B):682-9
references.pmid: 11114266
references.citation: Immunology. 1998 Nov;95(3):389-94
references.pmid: 9824502
references.citation: J Biol Chem. 1999 Mar 5;274(10):6421-31
references.pmid: 10037734
references.citation: Neurobiol Dis. 2007 Apr;26(1):153-64
references.pmid: 17240154
references.citation: Science. 2002 Jul 19;297(5580):353-6
references.pmid: 12130773
references.citation: Science. 2001 Aug 24;293(5534):1446-7
references.pmid: 11520974
references.citation: Vaccine. 2007 Jul 20;25(29):5348-58
references.pmid: 17582662
references.citation: Neurology. 2003 Jul 8;61(1):46-54
references.pmid: 12847155
references.citation: Exp Cell Res. 1982 Dec;142(2):437-45
references.pmid: 6293852
references.citation: J Neurosci. 2007 Nov 14;27(46):12565-76
references.pmid: 18003835
references.citation: Acta Neuropathol. 1995;89(6):544-51
references.pmid: 7676810
references.citation: Ann N Y Acad Sci. 2007 Oct;1113:173-7
references.pmid: 17656565
references.citation: J Neurosci. 2004 Jul 28;24(30):6799-809
references.pmid: 15282285
references.citation: J Neurosci Res. 2006 Jul;84(1):182-93
references.pmid: 16634056
references.citation: Neurobiol Aging. 2001 Nov-Dec;22(6):903-8
references.pmid: 11754997
references.citation: Mol Cell Biol. 1989 Mar;9(3):959-64
references.pmid: 2542770
references.citation: Neuroscience. 2006 Dec 1;143(2):461-75
references.pmid: 17008022
references.citation: J Cereb Blood Flow Metab. 1994 Jul;14(4):689-92
references.pmid: 8014217
references.citation: Neurosci Lett. 1995 Aug 4;195(2):105-8
references.pmid: 7478261
references.citation: J Neuropathol Exp Neurol. 1999 Nov;58(11):1163-9
references.pmid: 10560659
references.citation: J Psychiatr Res. 2007 Aug;41(5):387-94
references.pmid: 16554070
references.citation: J Biol Chem. 1995 Nov 10;270(45):26774-7
references.pmid: 7592914
references.citation: J Neuroimmunol. 2001 Feb 1;113(1):49-62
references.pmid: 11137576
references.citation: Biochem Biophys Res Commun. 2006 Jun 9;344(3):941-7
references.pmid: 16631618
references.citation: J Neuroimmunol. 1989 Oct;24(3):173-82
references.pmid: 2808689
references.citation: Ann Neurol. 2008 May;63(5):591-601
references.pmid: 18360829
references.citation: Parkinsonism Relat Disord. 2002 Jun;8(5):329-41
references.pmid: 15177062
references.citation: Glia. 2008 Feb;56(3):259-70
references.pmid: 18069670
references.citation: Infect Immun. 2001 Jul;69(7):4545-53
references.pmid: 11401998
references.citation: Stroke. 1997 Jun;28(6):1283-8
references.pmid: 9183363
references.citation: Neurotox Res. 2005 Nov;8(3-4):267-76
references.pmid: 16371321